Social determinants of health in multiple sclerosis
- PMID: 36369488
- PMCID: PMC9651126
- DOI: 10.1038/s41582-022-00735-5
Social determinants of health in multiple sclerosis
Abstract
Social determinants of health are the conditions in which people are born, grow, live, work and age. These circumstances are the non-medical factors that influence health outcomes. Evidence indicates that health behaviours, comorbidities and disease-modifying therapies all contribute to multiple sclerosis (MS) outcomes; however, our knowledge of the effects of social determinants - that is, the 'risks of risks' - on health has not yet changed our approach to MS. Assessing and addressing social determinants of health could fundamentally improve health and health care in MS; this approach has already been successful in improving outcomes in other chronic diseases. In this narrative Review, we identify and discuss the body of evidence supporting an effect of many social determinants of health, including racial background, employment and social support, on MS outcomes. It must be noted that many of the published studies were subject to bias, and screening tools and/or practical interventions that address these social determinants are, for the most part, lacking. The existing work does not fully explore the potential bidirectional and complex relationships between social determinants of health and MS, and the interpretation of findings is complicated by the interactions and intersections among many of the identified determinants. On the basis of the reviewed literature, we consider that, if effective interventions targeting social determinants of health were available, they could have substantial effects on MS outcomes. Therefore, funding for and focused design of studies to evaluate and address social determinants of health are urgently needed.
© 2022. Springer Nature Limited.
Conflict of interest statement
The authors declare no competing interests.
Figures


Similar articles
-
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881. Med J Aust. 2020. PMID: 33314144
-
Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.JBI Libr Syst Rev. 2009;7(13):492-582. doi: 10.11124/01938924-200907130-00001. JBI Libr Syst Rev. 2009. PMID: 27819974
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Achieving Health Equity in Hypertension Management Through Addressing the Social Determinants of Health.Curr Hypertens Rep. 2019 Jun 12;21(8):58. doi: 10.1007/s11906-019-0962-7. Curr Hypertens Rep. 2019. PMID: 31190099 Review.
-
Health Disparities, Inequities, and Social Determinants of Health in Multiple Sclerosis and Related Disorders in the US: A Review.JAMA Neurol. 2021 Dec 1;78(12):1515-1524. doi: 10.1001/jamaneurol.2021.3416. JAMA Neurol. 2021. PMID: 34605866 Review.
Cited by
-
Occupational risk factors for multiple sclerosis: a systematic review with meta-analysis.Front Public Health. 2023 Nov 16;11:1285103. doi: 10.3389/fpubh.2023.1285103. eCollection 2023. Front Public Health. 2023. PMID: 38054069 Free PMC article.
-
Advocacy for patients with headache disorders.eNeurologicalSci. 2023 May 10;31:100466. doi: 10.1016/j.ensci.2023.100466. eCollection 2023 Jun. eNeurologicalSci. 2023. PMID: 37250108 Free PMC article. Review.
-
Prophylactic administration of PEPITEM in experimental autoimmune encephalomyelitis delays disease onset, inhibits leukocyte infiltration, and alleviates severity.Int J Clin Exp Pathol. 2024 Dec 15;17(12):492-505. doi: 10.62347/LTAO2386. eCollection 2024. Int J Clin Exp Pathol. 2024. PMID: 39802871 Free PMC article.
-
The Polygenic Nature of Multiple Sclerosis: Genetic Variants, Immunological Modulation, and Environmental Connections.Endocr Metab Immune Disord Drug Targets. 2025;25(7):527-559. doi: 10.2174/0118715303325979241206115417. Endocr Metab Immune Disord Drug Targets. 2025. PMID: 39810445 Review.
-
The burden of myasthenia gravis - highlighting the impact on family planning and the role of social support.Front Neurol. 2023 Dec 14;14:1307627. doi: 10.3389/fneur.2023.1307627. eCollection 2023. Front Neurol. 2023. PMID: 38162439 Free PMC article.
References
-
- Multiple Sclerosis International Federation. Atlas of MS, 3rd edn. MS International Federationhttps://www.msif.org/wp-content/uploads/2020/12/Atlas-3rd-Edition-Epidem... (2020).
-
- Dobson R, Giovannoni G. Multiple sclerosis–a review. Eur. J. Neurol. 2019;26:27–40. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical